Annual report pursuant to Section 13 and 15(d)

Document And Entity Information

v3.21.1
Document And Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2020
Mar. 15, 2021
Jun. 30, 2020
Document Information [Line Items]      
Entity Registrant Name NAVIDEA BIOPHARMACEUTICALS, INC.    
Entity Central Index Key 0000810509    
Trading Symbol navb    
Current Fiscal Year End Date --12-31    
Entity Filer Category Non-accelerated Filer    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Well-known Seasoned Issuer No    
Entity Emerging Growth Company false    
Entity Small Business true    
Entity Interactive Data Current Yes    
Entity Common Stock, Shares Outstanding (in shares)   28,567,298  
Entity Public Float     $ 66,317,942
Entity Shell Company false    
Document Type 10-K    
Document Period End Date Dec. 31, 2020    
Document Fiscal Year Focus 2020    
Document Fiscal Period Focus FY    
Amendment Flag false    
Title of 12(b) Security Common Stock, par value $.001 per share